Related Experiment Videos
[Cardiovascular events: a class effect by COX-2 inhibitors]
Leila Fernandes Araujo1, Alexandre de Matos Soeiro, Juliano de Lara Fernandes
1Instituto do Coração, Hospital das Clínicas, FMUSP, São Paulo, SP.
Arquivos Brasileiros De Cardiologia
|October 4, 2005
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Performance and costs of rule-out protocols for acute aortic syndromes: analysis of pooled prospective cohorts.
European journal of internal medicine·2025
Antisense therapy to block the Kallikrein-kinin pathway in COVID-19: The ASKCOV randomized controlled trial.
Journal of critical care·2024
Artificial Intelligence Applied to Electrocardiogram-Based Cardiovascular Risk Assessment: A Systematic Review.
Arquivos brasileiros de cardiologia·2026
Arterial Stiffness, Clinical-Functional Outcomes, and Quality of Life in Post-COVID-19 Patients: A Cross-Sectional Study.
Arquivos brasileiros de cardiologia·2026
Normal Reference Values for Cardiovascular Magnetic Resonance: An Analytical-Comparative Review with Emphasis on the Brazilian Population.
Arquivos brasileiros de cardiologia·2026
Impact of Catheter Ablation on LVEF in Patients with Atrial Fibrillation and Heart Failure with Reduced Ejection Fraction: A Systematic Review.
Arquivos brasileiros de cardiologia·2026
Epidemiology and Mortality of Valvular Heart Disease in Brazilian Adults: Findings from the ELSA-Brasil Cohort.
Arquivos brasileiros de cardiologia·2026
NIR-Activated Enteric Prodrug Microparticles for Bioimaging-Guided Chemotherapy of Colorectal Cancer.
ACS applied materials & interfaces·2026
Protective effect of the bee bread on cadmium-induced testicular toxicity in rats.
Veterinary research forum : an international quarterly journal·2026
Stereotactic body radiotherapy for bone-only oligometastatic bladder Cancer: a multi-institutional experience.
Clinical and translational radiation oncology·2026
Efficacy and Safety of Sintilimab in Combination With Anlotinib and Chemoradiotherapy as First-Line Treatment for Driver Gene-Negative Oligometastatic Non-small Cell Lung Cancer: A Real-World Cohort Study.
Dose-response : a publication of International Hormesis Society·2026